• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受减重手术的患者中,阻塞性睡眠呼吸暂停的缺失可能有助于预防非酒精性脂肪肝。

The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery.

机构信息

Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2013 May 3;8(5):e62504. doi: 10.1371/journal.pone.0062504. Print 2013.

DOI:10.1371/journal.pone.0062504
PMID:23658732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3643948/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide and its progressive form, steatohepatitis, will be the leading indication for liver transplant by 2020. While risk factors for steatohepatitis have been identified, little work has been performed to identify factors protective against NAFLD development.

AIM

This study sought to identify factors predictive of normal liver histology in a bariatric cohort.

METHODS

Patients undergoing weight loss surgery with liver biopsies at the time of surgery were included. Patients with other causes of chronic liver disease were excluded.

RESULTS

One hundred fifty-nine patients were included. Forty-nine patients had normal liver histology and 110 patients had NAFLD. Several previously identified factors associated with normal liver histology were found. Black race was the strongest predictor of the absence of NAFLD with an odds ratio (OR) of 6.8, 95% confidence interval (CI) 2.4-18.9. Low HOMA-IR was also associated with normal histology (OR 1.4, 95% CI 1.03-1.9). In contrast, low HDL was associated with a decreased chance of normal histology (OR 0.38, 95% CI 0.05-0.83). Interestingly, a novel protective factor, the absence of obstructive sleep apnea (OSA) was strongly associated with normal histology (OR 5.6, 95% CI 2.0-16.1). In multivariate regression controlling for BMI, black race, absence of OSA, low HOMA-IR and low ALT independently predicted normal liver histology with an area under the ROC curve of 0.85.

CONCLUSIONS

Our study confirmed several factors associated with normal liver histology, including black race and identified a novel factor, absence of OSA. Further evaluation of these factors will allow for improved understanding of the pathogenesis of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是全球最常见的肝病病因,其进展形式——脂肪性肝炎,到 2020 年将成为肝移植的主要适应证。虽然已经确定了脂肪性肝炎的危险因素,但对于预防 NAFLD 发生的保护因素的研究却很少。

目的

本研究旨在确定肥胖患者队列中预测正常肝脏组织学的因素。

方法

纳入了接受减肥手术且术中进行肝脏活检的患者。排除了有其他原因导致的慢性肝病的患者。

结果

共纳入 159 例患者。其中 49 例患者的肝脏组织学正常,110 例患者患有 NAFLD。发现了一些与正常肝脏组织学相关的已确定的因素。黑种人是 NAFLD 缺失的最强预测因素,其优势比(OR)为 6.8,95%置信区间(CI)为 2.4-18.9。低 HOMA-IR 也与正常组织学相关(OR 1.4,95%CI 1.03-1.9)。相反,低 HDL 与正常组织学的可能性降低相关(OR 0.38,95%CI 0.05-0.83)。有趣的是,一个新的保护因素,即不存在阻塞性睡眠呼吸暂停(OSA),与正常组织学有强烈相关性(OR 5.6,95%CI 2.0-16.1)。在多元回归中,控制 BMI、黑种人、无 OSA、低 HOMA-IR 和低 ALT 后,这些因素独立预测正常肝脏组织学,ROC 曲线下面积为 0.85。

结论

本研究证实了与正常肝脏组织学相关的几个因素,包括黑种人,并确定了一个新的因素,即不存在 OSA。进一步评估这些因素将有助于更好地理解 NAFLD 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c46/3643948/dd4abfee6881/pone.0062504.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c46/3643948/dd4abfee6881/pone.0062504.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c46/3643948/dd4abfee6881/pone.0062504.g001.jpg

相似文献

1
The absence of obstructive sleep apnea may protect against non-alcoholic fatty liver in patients undergoing bariatric surgery.在接受减重手术的患者中,阻塞性睡眠呼吸暂停的缺失可能有助于预防非酒精性脂肪肝。
PLoS One. 2013 May 3;8(5):e62504. doi: 10.1371/journal.pone.0062504. Print 2013.
2
Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery.肥胖患者接受减重手术后的阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病。
Obes Surg. 2020 Jul;30(7):2572-2578. doi: 10.1007/s11695-020-04514-3.
3
Association between non-alcoholic fatty liver disease and obstructive sleep apnea.非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停的关系。
World J Gastroenterol. 2020 May 28;26(20):2669-2681. doi: 10.3748/wjg.v26.i20.2669.
4
Correlation between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease before and after Metabolic Bariatric Surgery.代谢减重手术后阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病的相关性。
Obes Surg. 2020 Oct;30(10):3803-3812. doi: 10.1007/s11695-020-04696-w.
5
Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.接受减肥手术患者的非酒精性脂肪性肝病患病率及脂肪性肝炎危险因素
Obes Surg. 2015 Dec;25(12):2335-43. doi: 10.1007/s11695-015-1696-5.
6
Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.非肥胖成年人阻塞性睡眠呼吸暂停与非酒精性脂肪性肝病之间的关系。
Sleep Breath. 2016 May;20(2):529-35. doi: 10.1007/s11325-015-1232-9. Epub 2015 Jul 15.
7
Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?非酒精性脂肪性肝病与阻塞性睡眠呼吸暂停相关:仅仅是巧合吗?
Obes Surg. 2010 Nov;20(11):1536-43. doi: 10.1007/s11695-010-0212-1.
8
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.重度肥胖患者中阻塞性睡眠呼吸暂停对非酒精性脂肪性肝病的影响。
Obesity (Silver Spring). 2016 Apr;24(4):871-7. doi: 10.1002/oby.21409. Epub 2016 Feb 16.
9
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎(NASH)和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
10
Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea.持续气道正压通气治疗阻塞性睡眠呼吸暂停患者非酒精性脂肪性肝病。
J Clin Sleep Med. 2018 Aug 15;14(8):1315-1322. doi: 10.5664/jcsm.7262.

引用本文的文献

1
Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.肥胖患者阻塞性睡眠呼吸暂停对非酒精性脂肪性肝病的影响:系统评价。
Int J Obes (Lond). 2023 Dec;47(12):1200-1213. doi: 10.1038/s41366-023-01378-2. Epub 2023 Sep 11.
2
Sleep disorder in patients with chronic liver disease: a narrative review.慢性肝病患者的睡眠障碍:一篇叙述性综述。
J Thorac Dis. 2020 Oct;12(Suppl 2):S248-S260. doi: 10.21037/jtd-cus-2020-012.
3
Obstructive Sleep Apnea and the Liver.阻塞性睡眠呼吸暂停与肝脏

本文引用的文献

1
Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.非高密度脂蛋白胆固醇作为非酒精性脂肪性肝炎的生物标志物。
Clin Gastroenterol Hepatol. 2012 Jun;10(6):651-6. doi: 10.1016/j.cgh.2012.01.017. Epub 2012 Feb 10.
2
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese.慢性间歇性低氧是病态肥胖非酒精性脂肪肝的主要触发因素。
J Hepatol. 2012 Jan;56(1):225-33. doi: 10.1016/j.jhep.2011.04.022. Epub 2011 May 19.
3
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.
Clin Liver Dis. 2019 May;23(2):363-382. doi: 10.1016/j.cld.2019.01.001.
4
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease.阻塞性睡眠呼吸暂停、低氧血症与非酒精性脂肪性肝病。
Am J Respir Crit Care Med. 2019 Apr 1;199(7):830-841. doi: 10.1164/rccm.201806-1109TR.
5
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.美国非酒精性脂肪性肝病患病率、严重程度和结局的种族和民族差异:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2. doi: 10.1016/j.cgh.2017.09.041. Epub 2017 Sep 29.
6
The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease.胰岛素样生长因子-1水平与非酒精性脂肪性肝病组织学严重程度之间的关联
Clin Transl Gastroenterol. 2017 Jan 26;8(1):e217. doi: 10.1038/ctg.2016.72.
7
The association between continuous positive airway pressure therapy and liver disease development in obstructive sleep apnea/hypopnea syndrome patients: a nationwide population-based cohort study in Taiwan.阻塞性睡眠呼吸暂停/低通气综合征患者持续气道正压通气治疗与肝病发生之间的关联:台湾一项基于全国人群的队列研究
Sleep Breath. 2017 May;21(2):461-467. doi: 10.1007/s11325-016-1439-4. Epub 2016 Dec 13.
8
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.YAP/TAZ-miR-130/301分子回路在人类疾病和生理状况网络中对纤维化发挥系统水平的调控作用。
Sci Rep. 2015 Dec 15;5:18277. doi: 10.1038/srep18277.
9
Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity.阻塞性睡眠呼吸暂停对肝脏脂肪堆积的影响:基于性别和内脏肥胖的研究
PLoS One. 2015 Jun 15;10(6):e0129513. doi: 10.1371/journal.pone.0129513. eCollection 2015.
10
Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.阻塞性睡眠呼吸暂停与非酒精性脂肪性肝炎及肝脏组织学进展相关。
Dig Dis Sci. 2015 Aug;60(8):2523-8. doi: 10.1007/s10620-015-3650-8. Epub 2015 Apr 4.
缺氧加重肝细胞 PTEN 缺失小鼠的非酒精性脂肪性肝炎。
Clin Sci (Lond). 2009 Dec 14;118(6):401-10. doi: 10.1042/CS20090313.
4
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?非酒精性脂肪性肝病中心血管疾病风险增加:因果效应还是附带现象?
Diabetologia. 2008 Nov;51(11):1947-53. doi: 10.1007/s00125-008-1135-4. Epub 2008 Sep 2.
5
Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.一项基于人群的队列研究中疑似非酒精性脂肪性肝病与死亡风险
Am J Gastroenterol. 2008 Sep;103(9):2263-71. doi: 10.1111/j.1572-0241.2008.02034.x. Epub 2008 Aug 5.
6
Recent advances in nonalcholic fatty liver disease.非酒精性脂肪性肝病的最新进展
Curr Opin Gastroenterol. 2008 May;24(3):320-7. doi: 10.1097/MOG.0b013e3282fbccf2.
7
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?非酒精性脂肪性肝病中的肝硬化和肝衰竭:小题大做还是问题严重?
Hepatology. 2008 May;47(5):1431-3. doi: 10.1002/hep.22246.
8
Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea.在阻塞性睡眠呼吸暂停患者中,血清转氨酶水平与缺氧标志物相关。
Sleep. 2008 Jan;31(1):121-6. doi: 10.1093/sleep/31.1.121.
9
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.慢性间歇性低氧在饮食诱导的脂肪肝小鼠模型中引发肝炎。
Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G871-7. doi: 10.1152/ajpgi.00145.2007. Epub 2007 Aug 9.
10
Nonalcoholic fatty liver disease in severely obese subjects.严重肥胖受试者的非酒精性脂肪性肝病
Am J Gastroenterol. 2007 Feb;102(2):399-408. doi: 10.1111/j.1572-0241.2006.01041.x.